UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Raised by Oxford Wealth Group LLC

Oxford Wealth Group LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,614 shares of the healthcare conglomerate’s stock after purchasing an additional 195 shares during the quarter. UnitedHealth Group comprises 1.2% of Oxford Wealth Group LLC’s portfolio, making the stock its 16th largest position. Oxford Wealth Group LLC’s holdings in UnitedHealth Group were worth $1,828,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Western Pacific Wealth Management LP boosted its position in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after acquiring an additional 19 shares during the period. MCF Advisors LLC increased its stake in UnitedHealth Group by 0.8% during the 4th quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after buying an additional 20 shares during the period. Axiom Financial Strategies LLC raised its holdings in UnitedHealth Group by 3.6% during the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after purchasing an additional 20 shares in the last quarter. Richwood Investment Advisors LLC boosted its stake in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after purchasing an additional 20 shares in the last quarter. Finally, 44 Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 1.6% in the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after buying an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $427.10 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $417.12 and a 12-month high of $630.73. The business’s 50-day simple moving average is $508.83 and its 200 day simple moving average is $537.99. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $390.67 billion, a price-to-earnings ratio of 27.55, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the firm posted $6.91 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Analysts Set New Price Targets

UNH has been the subject of several research reports. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating for the company in a research report on Monday. Raymond James reiterated a “strong-buy” rating and set a $540.00 price objective (down previously from $635.00) on shares of UnitedHealth Group in a research report on Monday. HSBC reaffirmed a “hold” rating and set a $490.00 target price on shares of UnitedHealth Group in a research report on Tuesday. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Finally, Truist Financial cut their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating on the stock in a report on Monday. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $608.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.